Brokerages expect Colfax Corp (NYSE:CFX) to post earnings per share (EPS) of $0.56 for the current quarter, Zacks reports. Six analysts have provided estimates for Colfax’s earnings. The lowest EPS estimate is $0.46 and the highest is $0.66. Colfax reported earnings of $0.69 per share during the same quarter last year, which indicates a negative year-over-year growth rate of 18.8%. The business is expected to report its next earnings results on Wednesday, February 12th.
On average, analysts expect that Colfax will report full-year earnings of $1.98 per share for the current financial year, with EPS estimates ranging from $1.95 to $2.03. For the next year, analysts anticipate that the business will report earnings of $2.25 per share, with EPS estimates ranging from $2.15 to $2.49. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side analysts that follow Colfax.
Colfax (NYSE:CFX) last issued its quarterly earnings data on Thursday, October 31st. The industrial products company reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.04. The firm had revenue of $846.52 million for the quarter, compared to analyst estimates of $852.39 million. Colfax had a negative net margin of 12.40% and a positive return on equity of 9.06%. The firm’s revenue was up 61.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.22 EPS.
Shares of NYSE CFX traded up $1.15 during midday trading on Friday, reaching $34.58. 50,962 shares of the company’s stock were exchanged, compared to its average volume of 1,471,568. Colfax has a 52-week low of $18.95 and a 52-week high of $36.63. The stock has a market capitalization of $3.97 billion, a PE ratio of 14.95, a price-to-earnings-growth ratio of 2.56 and a beta of 1.64. The company has a debt-to-equity ratio of 1.32, a quick ratio of 1.94 and a current ratio of 2.32. The business’s fifty day moving average price is $32.91 and its two-hundred day moving average price is $28.58.
In related news, EVP Daniel A. Pryor sold 4,825 shares of Colfax stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $33.32, for a total transaction of $160,769.00. Following the completion of the transaction, the executive vice president now directly owns 79,689 shares of the company’s stock, valued at approximately $2,655,237.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Shyam Kambeyanda sold 4,100 shares of the business’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $36.06, for a total transaction of $147,846.00. Following the completion of the transaction, the senior vice president now owns 47,163 shares in the company, valued at $1,700,697.78. The disclosure for this sale can be found here. 12.00% of the stock is owned by insiders.
Large investors have recently bought and sold shares of the company. Parallel Advisors LLC grew its position in Colfax by 176.4% during the 2nd quarter. Parallel Advisors LLC now owns 1,252 shares of the industrial products company’s stock worth $35,000 after acquiring an additional 799 shares during the last quarter. Cerebellum GP LLC acquired a new stake in Colfax during the 3rd quarter valued at $82,000. Nisa Investment Advisors LLC acquired a new stake in Colfax during the 2nd quarter valued at $83,000. Dupont Capital Management Corp bought a new position in Colfax in the 3rd quarter valued at $218,000. Finally, Fox Run Management L.L.C. bought a new position in Colfax in the 3rd quarter valued at $225,000. Institutional investors own 99.06% of the company’s stock.
Colfax Company Profile
Colfax Corporation operates as a diversified technology company worldwide. The company operates through Air and Gas Handling, and Fabrication Technology segments. The Air and Gas Handling segment designs, manufactures, installs, and maintains heavy-duty fans, rotary heat exchangers, blowers, and compressors.
See Also: Return on Investment (ROI)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.